Revolutionary sonic-based transdermal system joins Juventix's lineup of non-invasive and minimally invasive PRP and biologics delivery solutions, offering safe and effective access to regenerative therapies for a broader range of providers.
The report covers 2023 sales data of innovator therapeutic antibodies and proteins, biosimilars and the novel biologic drug modalities gene & cell therapy and RNA products
